Pfizer has received a “Moderate Buy” consensus from fifteen analysts, signaling cautious optimism rather than fanfare. One ...

We recently published a list of Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential. In this ...

Employees from the Collegeville location of Pfizer spent some time this week pitching in to renovate a Reading home for a local family in need. The volunteers spent Wednesday hanging drywall at a ...

Pfizer will also share new findings highlighting the company’s strategy to explore novel vedotin antibody-drug conjugates (ADCs) in combination with immune checkpoint inhibitors to potentially ...

Two brand-name, time-tested companies -- sporting an average yield of 7% -- are ripe for the picking amid a historic bout of ...

Last week, Pfizer announced that it would no longer develop danuglipron, a daily GLP-1 weight-loss drug which investors were excited about as a potential blockbuster for the company. This wasn't ...

May not be hydrating enough for very dry skin This cream “gives the eye area intense moisture for ... I have already gone through a full tube, and that’s rare for me. It looks beautiful ...

Revenue Growth: Over the 3M period, Pfizer showcased positive performance, achieving a revenue growth rate of 21.93% as of 31 December, 2024. This reflects a substantial increase in the company's ...

What is the purpose of the fund? The company has rolled out this close-ended fund for non-retail investors with some to restricted investors for long term investments in global equity exchange-traded ...